Kangwei Century (688426.SH) announced that recently, the company's wholly-owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd...
According to Zhitong Finance APP, Kangwei Century (688426.SH) announced that recently, its wholly-owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd. (hereinafter referred to as 'Jianwei Diagnostics') has independently developed and produced a test kit for detecting antibiotic-resistant genes of Helicobacter pylori (based on fecal samples), which has received a Class III 'medical instruments registration certificate' issued by the National Medical Products Administration.
As of the date of this announcement, Jianwei Diagnostics' independently developed and produced Helicobacter pylori antibiotic-resistant gene testing kit, namely the Helicobacter pylori 23SrRNA/gyrA gene mutation testing kit (fluorescence PCR melting curve method), is the first in the country to obtain a Class III registration certificate for Helicobacter pylori antibiotic-resistant gene mutation testing kit (based on fecal samples). The acquisition of the above certificate helps enhance the company's competitiveness in the field of Helicobacter pylori diagnosis and treatment, which not only has a positive impact on the company's sales and business development but also has significant clinical value and social significance in the control of Helicobacter pylori infections in China.
